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Abstract
Background: Streptococcus pneumoniae is a common colonizer of the human nasopharynx and one of the major pathogens
causing invasive disease worldwide. Dissection of the molecular pathways responsible for colonization, invasion, and
evasion of the immune system will provide new targets for antimicrobial or vaccine therapies for this common pathogen.
Methodology/Principal Findings: We have constructed mutants lacking the pneumococcal cell wall hydrolases (CWHs) LytB
and LytC to investigate the role of these proteins in different phases of the pneumococcal pathogenesis. Our results show
that LytB and LytC are involved in the attachment of S. pneumoniae to human nasopharyngeal cells both in vitro and in vivo.
The interaction of both proteins with phagocytic cells demonstrated that LytB and LytC act in concert avoiding
pneumococcal phagocytosis mediated by neutrophils and alveolar macrophages. Furthermore, C3b deposition was
increased on the lytC mutant confirming that LytC is involved in complement evasion. As a result, the lytC mutant showed a
reduced ability to successfully cause pneumococcal pneumonia and sepsis. Bacterial mutants lacking both LytB and LytC
showed a dramatically impaired attachment to nasopharyngeal cells as well as a marked degree of attenuation in a mouse
model of colonization. In addition, C3b deposition and phagocytosis was more efficient for the double lytB lytC mutant and
its virulence was greatly impaired in both systemic and pulmonary models of infection.
Conclusions/Significance: This study confirms that the CWHs LytB and LytC of S. pneumoniae are essential virulence factors
involved in the colonization of the nasopharynx and in the progress of invasive disease by avoiding host immunity.
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Introduction
Streptococcus pneumoniae, the pneumococcus, is a major cause of
bacterial sepsis and the most common etiologic agent in acute
otitis media, community-acquired pneumonia as well as non-
epidemic bacterial meningitis [1,2]. Pneumococcal disease is
preceded by colonization, which is particularly common in
children, with more than one serotype frequently colonizing the
nasopharynx of the same individual at the same time [1]. Direct
bacterial translocation from the nasopharynx to the bloodstream,
generally known as occult bacteremia, is a well-recognized
complication of pneumococcal carriage, particularly in early
childhood [3]. Pneumococcal colonization involves binding of
the bacterium to cell-surface carbohydrates such as N-acetyl-
glycosamine on the respiratory epithelium and this process is
mediated by cell-wall-associated surface proteins [1]. Cell wall
hydrolases (CWHs) are surface enzymes that cleave specific
covalent bonds of the cell wall and eventually, cause the lysis
and death of the bacteria [4]. Among these proteins, LytB is a
CWH located at sites closely related to the polar ends of the cell.
This enzyme has N-acetylglucosaminidase activity and plays an
essential role in daughter cell separation [5,6]. Moreover, it has
been suggested that LytB, regardless of being polymorphic [7],
might be a promising target for the development of a universal
pneumococcal vaccine because an anti-LytB antiserum signifi-
cantly protected mice from a lethal challenge with different
pneumococcal strains [8]. Other well-characterized CWHs
include the LytC lysozyme that, in contrast to LytB, has a general
cell-surface distribution [9]. LytC is a protein that behaves as an
autolysin at 30uC and the fact that it has its maximum enzymatic
activity at this temperature suggests that it might be more crucial
in the upper respiratory tract [10]. LytC is one of the major
bacterial components that enable S. pneumoniae to lyse non-
competent pneumococci (fratricide) [11]. Indeed, fratricide has
been proposed as a mechanism of predation that contributes to
virulence by regulating the release of several virulence factors [11].
Although much work has been done under in vitro conditions,
whether CWHs are important virulence factors involved in direct
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interaction with the host surfaces or in the establishment of the
pneumococcal pathogenesis has not been clearly defined. As a
common colonizer of the upper respiratory tract, S. pneumoniae has
developed an arsenal of components that are of great importance
for biofilm formation and efficient colonization of the nasopharynx
which is the first step of pneumococcal virulence [12]. Inactivation
of LytB and LytC has been shown to hinder biofilm formation
whereas simultaneous disruption of both CWHs markedly reduced
biofilm establishment, which may suggest that both enzymes are
important pneumococcal components with additive or synergistic
effects upon bacterial adhesion [13]. In this sense, using single lytB
and lytC mutants on an unencapsulated type 4 strain, it has been
shown that loss of LytC but not LytB showed a moderate impaired
attachment to nasopharyngeal cells at 30uC but not a 37uC
whereas no attenuation was found in pneumococcal sepsis for both
mutations [14]. Besides, as the most common cause of community
acquired pneumonia, the ability of S. pneumoniae to invade the
pulmonary compartment and escape from the immune system is a
key event in the pathogenesis of pneumococcal pneumonia and
invasive disease. Therefore, the characterization of virulence
factors involved in pathogenesis is necessary to understand the
molecular basis of pneumococcal disease and allow identification
of new targets for the prevention and treatment of S. pneumoniae
infection.
In this study, we have constructed isogenic mutants lacking
LytB and/or LytC to analyze their role in the engagement and
persistence of S. pneumoniae in the upper respiratory tract. We have
also investigated the role of these proteins in evasion of
complement immunity and phagocytosis. Finally, we have
explored the implication of LytB and LytC in the establishment
of pneumococcal pneumonia and bacterial dissemination through-
out the systemic circulation.
Materials and Methods
Ethics Statement
The part of the study including serum sampling from healthy
volunteer controls as a source of complement was approved by the
Centro de Investigaciones Biolo´gicas (CIB) Research Ethics
Committee and was obtained following institutional guidelines.
Animals were bred at our Institution’s animal facilities whereas the
scientific procedures were performed at Fundacio´n Jime´nez Dı´az
(FJD) following institutional guidelines for animal use and care.
Infection experiments conformed to the Spanish government
legislation (RD 1201/2005) and European Community regulations
(86/609/EEC). The Animal Care and Use Committees of both
Institutions approved all the experiments involving animals in this
study (Approval Reference: CIB-FJD 06010017).
Bacterial strains and growth conditions
The S. pneumoniae clinical isolates used in the present study were
TIGR4 (serotype 4) [15] and D39 (serotype 2) [16]. Isogenic lytB
or lytC mutants of TIGR4 and D39 strains were constructed by
transformation with DNA prepared from mutants previously
characterized in our laboratory [5,13]. Kanamycin (250 mg ml21)
and tetracycline (0.5 mg ml21) were added to blood agar plates
when required. The lytB lytC double mutants were constructed by
transforming lytB mutants with DNA obtained from a lytC strain.
The accuracy of the mutations was confirmed by PCR using
specific primers. S. pneumoniae strains were incubated at 37uC on
blood agar plates (with or without antibiotics) in a 5% CO2
atmosphere, or in Todd-Hewitt broth supplemented with 0.5%
yeast extract, to an optical density at 550 nm of 0.5, corresponding
to ca. 108 CFU ml21, and stored at –70uC in 10% glycerol as
single-use aliquots.
In vitro studies
a) Attachment to nasopharyngeal cells. Monolayers of
human nasopharyngeal Detroit-562 (D562) cells (CCL138;
ATCC) were cultured to 90–95% confluence in tissue culture
flasks or in plates containing RPMI 1640 supplemented with 10%
heat-inactivated fetal calf serum, 1% glutamine, and 1 mM
sodium pyruvate [17]. Tissue culture 24-well plates containing
105 cells per well were infected in triplicate with the pneumococcal
isolates at a ratio of 10 bacteria:1 cell and incubated at 30uC or
37uC for 1 h. Afterwards, infected plates were washed three times
with phosphate-buffered saline (PBS; pH 7.3) and adherent
bacteria were lifted off by treatment firstly with 200 ml per well
of a solution containing 0.25% trypsin-1 mM EDTA and then
with 200 ml per well of 0.025% Triton X-100 (in PBS) as
previously described [17]. To determine the proportion of bacteria
recovered from infected cells, serial dilutions were plated and
counted. Experiments were repeated three times and results were
expressed as the proportion of bacteria recovered from D562 cells
infected with the different mutants in comparison to the control
groups of cells infected with the D39 and TIGR4 wild-type strains.
b) C3b binding to S. pneumoniae. Serum samples from five
healthy male volunteer controls (median age of 40 years) were
obtained according to institutional guidelines and stored as single-
use aliquots at –70uC to use as a source of complement. C3b
deposition on the S. pneumoniae surface was analyzed using a flow
cytometry assay [18,19]. Briefly, C3b deposition was investigated
by incubating 107 CFU of S. pneumoniae with 10 ml of pooled
human serum (diluted to 20% in PBS) for 20 minutes at 30uC or
37uC. After two washes in PBS-Tween 20 (0.01%), C3b bound to
the different strains was labeled with 50 ml of a 1/500 dilution of
fluorescein isothiocyanate-conjugated polyclonal goat anti-human
C3b antibody (ICN). The detection of C3b binding was performed
using a FACS Calibur flow cytometer (BD Biosciences) with gating
based on the analysis of at least 25,000 bacteria [18]. Experiments
were repeated three times and the results were expressed as the
proportion of C3b deposition on the surface of the different
mutants compared to the C3b deposition on the D39 wild-type
strain. Bacteria incubated with PBS instead of serum were
included as a negative control [18,19]. Additional experiments
of C3b deposition were performed in the presence or absence of
2 mg of the purified proteins LytB and/or LytC to assess
restoration of C3b levels.
c) Phagocytosis of S. pneumoniae. c1- By mice alveolar
macrophages. Experiments testing murine alveolar macrophage
phagocytosis were performed as previously described [20]. Briefly,
monolayers of MH-S cells (CRL-2019; ATCC) were grown in
RPMI 1640 tissue culture medium supplemented with 10% heat-
inactivated fetal calf serum and HEPES (10 mM). Cells seeded in
24-well plates containing 76105 cells per well were infected in
triplicate with 50 ml of a suspension of the pneumococcal isolates
at a ratio of 50 bacteria:1 cell and incubated at 37uC. For adhesion
assays, cells were infected for 1 h, washed five times with PBS and
lysed with 300 ml of a solution containing 0.025% saponin-PBS for
10 minutes at room temperature. Viable bacteria recovered from
infected cells were obtained by plating serial dilutions on blood
agar plates. For phagocytosis assays, cells previously infected with
the different strains for 1 h were washed five times with PBS and
incubated for an additional hour in tissue culture medium
containing penicillin (10 mg/ml) and gentamicin (200 mg ml21)
to kill extracellular bacteria. Bacterial counts were obtained from
cells washed three times with PBS and lysed as explained above.
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Experiments were repeated three times and results were expressed
as CFU/ml of bacteria recovered from MH-S cells infected with
the different mutants in comparison to cells infected with the D39
wild-type strain as a control.
c2- By human neutrophils. Experiments investigating human
neutrophil phagocytosis were performed using a flow cytometry
opsonophagocytic assay including S. pneumoniae labeled with 5, 6-
carboxyfluorescein succinimidyl ester (Molecular Probes) and HL-
60 cells (CCL-240; ATCC) differentiated to granulocytes [21,22].
This study was performed using the D39 wild type strain and
isogenic single lytB, lytC and the double lytB lytC mutant strains.
Differentiation into granulocytes was confirmed before the assays
using a monoclonal antibody to CD11b (kindly supplied by Prof.
C. Bernabeu, CIB-CSIC) which is a marker of granulocytic
differentiation [23]. A minimum of 6,000 cells were analyzed using
a Cytomics FC500 Beckman Coulter flow cytometer equipped
with a 488 nm Ar-ion laser. Experiments were repeated three
times and bacteria incubated in PBS instead of pooled human
serum (20% diluted in PBS) were used as a negative control.
Results were expressed as a fluorescence index defined as the
proportion of positive cells for fluorescent bacteria multiplied by
the geometric mean of fluorescence intensity which correlates with
the amount of bacteria phagocytosed per cell [21,24]. Additional
experiments of phagocytosis by human neutrophils were per-
formed in the presence or absence of 2 mg of the purified proteins
LytB and/or LytC to assess prevention of phagocytosis by the
CWHs LytB and LytC of S. pneumoniae.
In vivo studies
a) Colonization mice model. To investigate the ability of
the wild-type strains to induce a prolonged colonization of mice,
groups of five C57BL/6 mice (8 to 16 weeks old) under anesthesia
with isofluorane were inoculated by the intranasal route with 10 ml
of a suspension containing 109 CFU/ml of each of the wild-type
strains (TIGR4 and D39). Animals were sacrificed daily during a
period of 7 days and bacterial counts were obtained from the
nasopharyngeal lavage fluid. For the studies analyzing
nasopharyngeal colonization of the wild-type strains (used as
controls) vs. the single and double mutant strains, groups of at least
five C57BL/6 mice under anesthesia with isofluorane were
inoculated intranasally with 109 CFU/ml (in a volume of 10 ml
containing 107 CFU) of each strain in separate groups of mice
[25,26]. At 24 h and 120 h after challenge, a lethal dose of
pentobarbital was administered. Nasopharyngeal lavage fluid was
collected, diluted and plated for determination of viable bacteria.
Experiments were repeated twice using 5 mice in each group.
Results were expressed as Log CFU/ml of bacteria recovered from
the nasopharyngeal lavage fluid.
b) Pneumonia and sepsis mice model. For experiments
investigating the role of the different CWHs in the establishment of
pneumococcal pneumonia and sepsis, inoculation and sample
collection were performed in groups of 5 CD-1 mice (8 to 16 weeks
old) as previously described [18]. Mixed infection experiments in a
1:1 ratio, were used to calculate the competitive index (CI) defined
as the ratio of the test strain (single or double mutant) compared to
the control strain (wild-type or a single mutant strain, respectively)
recovered from mice divided by the ratio of the test strain to the
control strain in the inoculum [18,27]. A CI of ,1 indicates that
the test strain is attenuated in virulence compared to the control
strain. The lower the CI the more attenuated the strain. For the
sepsis model of infection, mice were inoculated by the
intraperitoneal route with a total of 56105 CFU/ml (in a
challenge suspension of 200 ml containing 56104 CFU of each
strain as a mixed infection in a 1:1 ratio) and the CI was calculated
for bacteria recovered from the spleen after 24 h. For the
pneumonia model, mice under anesthesia with isofluorane were
infected by the intranasal route with a total of 46108 CFU/ml (in
a volume of 50 ml containing 16107 CFU of each strain as a
mixed infection in a 1:1 ratio) and the CIs were calculated from
bacteria recovered from bronchoalveolar lavage fluid (BALF), lung
and blood after 24 h. CI experiments were repeated twice using 5
mice in each group and were performed using D39 wild-type
strain and isogenic lytB, lytC and the double lytB lytC mutant
strains.
Statistical analyses
Data are representative of results obtained from repeated
independent experiments, and each data point represents the
mean and standard deviations (SD) for 3 to 5 replicates. Statistical
analysis was performed by using two-tailed Student’s t test (for two
groups), whereas analysis of variance (ANOVA) was chosen for
multiple comparisons. GraphPad InStat version 3.0 (GraphPad
Software, San Diego, CA) was used for statistical analysis.
Results
LytB and LytC are important surface proteins involved in
the attachment of S. pneumoniae to human
nasopharyngeal cells
The ability of lytB and lytC mutants to adhere to nasopharyngeal
cells at 37uC or 30uC was investigated using two different strains
(TIGR4 and D39). Loss of either LytB or LytC in both serotypes
caused a significant reduction in the capacity of S. pneumoniae to
attach to the D562 cells at either temperature (Fig. 1) demon-
strating that both CWHs play an important role in nasopharyn-
geal colonization. The proportion of bacterial attachment
appeared to be slightly lower (P ,0.05) for D39 lytC (48.3%68
SD) than for D39 lytB mutants (65%612 SD) when incubated at
30uC which is the optimal temperature of the LytC lysozyme
activity. To investigate whether both LytB and LytC hydrolases
collaborate in promoting efficient attachment to nasopharyngeal
cells, double mutants were also evaluated. The proportion of lytB
lytC TIGR4 and D39 derivatives attached to the D562 cells was
greatly reduced at both temperatures compared to the wild-type
and the single mutant strains, with a very significant impairment at
30uC for both serotypes (Fig. 1).
LytB and LytC are key cell wall hydrolases in
nasopharyngeal colonization
To investigate the involvement of LytB and LytC in
nasopharyngeal colonization under in vivo conditions, we first
evaluated whether a high dose of bacteria was able to induce
prolonged colonization of mice. To confirm the viability in the
mouse model of infection, TIGR4 and D39 wild-type strains were
inoculated by the intranasal route and the concentration of
bacteria present in the nasopharynx was determined. Nasopha-
ryngeal colonization was maintained with bacterial levels between
104 and 105 CFU/ml (median levels 1.616104 CFU/ml and
2.516104 CFU/ml for D39 and TIGR4 strain, respectively)
throughout the whole period of the study (7 days) (Fig. 2A). The
animals did not develop bacteremia as blood collected daily to
explore the presence of bacteria in the systemic circulation was
sterile at all the time-points investigated (data not shown). S.
pneumoniae mutants lacking either LytB or LytC showed an
impaired colonizing capacity, with a dramatic effect for lytC along
time, demonstrating that these important surface-exposed proteins
are involved in the adhesion and colonization of the mucosal
Cell Wall Hydrolases and Pneumococcal Disease
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surfaces lining the nasopharynx (Fig. 2B–2C). Moreover, the lytB
lytC double mutants were even less capable of colonizing the mice
than the corresponding single mutants, which confirm that the
combination of LytB and LytC is highly effective for the
establishment of the carrier state.
C3b deposition is enhanced on the surface of lytC and
lytB lytC strains
To analyze the interaction of the different CWHs with the
complement system, a flow cytometry assay was performed. C3b
deposition was measured on the bacterial surface of the different
mutants and the wild-type strain on a D39 background as this
strain has been commonly used worldwide to investigate the
interaction of different proteins of S. pneumoniae with the
complement system [18,28,29]. Binding of the key complement
component C3b to the lytB strain was similar to the wild-type
strain at both 30uC and 37uC showing that LytB is not required
for binding of the C3b component (Fig. 3). However, C3b
deposition was increased on the lytC background at both
temperatures suggesting that LytC avoids complement immunity
by targeting C3b (Fig. 3). The double mutant was also found to
bind C3b at higher level than wild-type or single mutants,
confirming that the combination of both LytB and LytC is highly
effective in the inhibition of the complement activity. Addition of
exogenous purified proteins restored C3b levels to those found for
the wild-type strain demonstrating that the increased C3b
deposition on the lytC and lytB lytC mutants was due to the
absence of the proteins (Fig. 3E).
LytB and LytC hinder S. pneumoniae recognition and
engulfment by murine alveolar macrophages
The lung contains alveolar macrophages which are both
sentinels and the first line of defense against infection and
clearance of S. pneumoniae from lungs and blood depends on the
efficiency of host phagocytes to recognize and destroy the
pathogen. Phagocytosis experiments were performed using the
murine MH-S cell line to investigate the ability of alveolar
macrophages to phagocytose the mutants lacking different CWHs
compared to the D39 wild-type strain. Adhesion to the alveolar
macrophage cell line was slightly, but significantly increased for
the lytB strain compared to the wild-type strain while no difference
was detected between the wild-type and the lytC mutant (Fig. 4A).
However, phagocytosis was significantly increased for both lytB
and lytC mutants suggesting that each of the CWHs are involved in
evasion of phagocytosis by alveolar macrophages (Fig. 4B).
Furthermore, loss of both CWHs had a marked increased on
Figure 1. Proportion of bacteria recovered from D562 cells infected with wild-type or defective strains in CWHs. D562 cells were
incubated at 37uC (solid bars) or 30uC (hatched bar). Error bars represent the SDs, and asterisks mark results that are statistically significant compared
with wild-type strains (two-tailed Student’s t test; *, P,0.05; **, P,0.01; ***, P,0.001). (A) TIGR4 strain and isogenic mutants. P,0.01 (lytB vs. lytB lytC)
and P = 0.09 (lytC vs. lytB lytC) (Student’s unpaired t test, 2-tailed). P,0.001 for the overall comparison (one-way ANOVA with a post hoc Dunnett test).
(B) D39 strain and isogenic mutants. For the lytB lytC double mutant vs. lytB or lytC single mutants: P,0.001 (Student’s unpaired t test, two-tailed).
P,0.001 for the overall comparison (one-way ANOVA with a post hoc Dunnett test).
doi:10.1371/journal.pone.0023626.g001
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pneumococcal adhesion and phagocytosis compared to the wild-
type and the single mutant strains, indicating that the presence of
LytB and LytC is of great importance for resistance to
phagocytosis mediated by alveolar macrophages (Fig. 4C).
LytB and LytC enhance the resistance to neutrophil
phagocytosis
The complement system is a key component of the immune
system involved in phagocytosis of invading pathogens in the
systemic circulation and indeed, complement receptors for C3b /
iC3b are one of the primary receptors on human neutrophils
which mediate opsonophagocytosis of pneumococci and other
encapsulated bacteria. The presence of complement receptors on
HL-60 granulocytes has been previously documented [23] and
therefore expression of CD11b (iC3b receptor and CR3 a-chain),
a marker of granulocytic differentiation, was measured prior to
phagocytic assays to confirm the presence of the receptor (data not
shown). Phagocytosis of lytB and lytC single mutants was
significantly increased indicating that both CWHs are involved
in the evasion of uptake by human neutrophils (Figs. 5A and B).
Moreover, the phagocytosis of the lytB lytC double mutant strain
was markedly increased compared to the wild-type and the single
mutants, demonstrating that LytB and LytC together, are highly
effective in diverting neutrophil-mediated phagocytosis.
It is well documented that choline-binding proteins of S.
pneumoniae, such as the CWHs studied here, bind rapidly and
specifically to the choline residues located at the pneumococcal
surface when added to a bacterial culture [4,5]. To investigate
further whether LytB and LytC in combination are more effective
at preventing phagocytosis of S. pneumoniae than each protein
alone, phagocytosis assays were repeated in the presence of the
corresponding purified proteins. These experiments confirmed
that the enhanced phagocytosis of the mutant strains was mainly
due to the absence of the CWHs providing further evidence that
the proteins in combination had a pronounced activity on
pneumococcal avoidance of phagocytosis (Fig. 5C).
LytB and LytC contribute to pneumococcal sepsis
To investigate the effect of lytB and lytC mutations on the virulence
of S. pneumoniae, CIs were determined in a mouse sepsis model. The
CI for the lytB mutant strain was close to 1 indicating that LytB by
itself does not have a significant role in the establishment of
pneumococcal sepsis (Fig. 6A). However, the CI was reduced for the
lytC mutant compared to the wild-type strain, showing a significant
attenuation in virulence in this model of infection (Fig. 6A). In
addition, reduced CIs were also obtained for the double lytB lytC
mutant strain compared to the D39 parent strain, demonstrating that
loss of both LytB and LytC impairs virulence significantly compared
Figure 2. Nasopharyngeal colonization by clinical S. pneumoniae isolates and CWHs mutants in a mouse model. (A) Colonization curve
of mice inoculated intranasally with S. pneumoniae TIGR4 (triangles) and D39 (circles). Number of pneumococci recovered from the nasopharynx of
the infected mice is expressed as Log10 CFU ml
21. (B) Results of the nasopharyngeal colonization levels at 24 h from mice infected with TIGR4 (open
bars) or D39 (solid bars) and the correspondent lytB, lytC and lytB lytC mutant strains. Error bars represent the SDs, and asterisks mark results that are
statistically significant compared with wild-type strains (two-tailed Student’s t test; *, P,0.05; **, P,0.01; ***, P,0.001). For the lytB lytC double
mutant strain vs. lytB or lytC mutants, P values are: P,0.01 for TIGR4 and P,0.001 for D39 (Student’s unpaired t test, 2-tailed). P,0.001 for the overall
comparison (one-way ANOVA with a post hoc Dunnett test). (C) Nasopharyngeal colonization levels at 120 h from mice infected with D39 and the
correspondent lytB, lytC, and lytB lytC mutants. Error bars represent the SDs, and asterisks mark results that are statistically significant compared with
the wild-type strain (two-tailed Student’s t test; ***, P,0.001). P,0.001 for the overall comparison (one-way ANOVA with a post hoc Dunnett test).
doi:10.1371/journal.pone.0023626.g002
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to the single mutants and the wild-type strain (Fig. 6A). To confirm
that loss of both LytB and LytC results in a cooperative reduction in
virulence, mixed infections of the lytB lytC mutant vs. the lytC strain
were performed. As the lytC mutation is present in both strains, the CI
(lytC vs. lytB lytC) should be similar to the corresponding CI for the lytB
vs. wild-type strain. However, if the CI is lower, the results would
indicate an additive or synergistic phenotype of mutations affecting
independent functions involved in systemic infection [18,27]. Mixed
infections of the lytC vs. lytB lytC were performed in a sepsis model of
infection showing a significantly lower CI than the CI found for the
lytB strain vs. the wild-type D39 strain (Fig. 6B), confirming that loss
of both LytB and LytC has additive effects on virulence.
Lack of both LytB and LytC is associated with an impaired
pneumococcal pneumonia
To further analyze the role of LytB and LytC on pneumococcal
pneumonia, strains lacking each CWH and the wild-type strain
were inoculated as mixed infections and their role in virulence
Figure 3. C3b deposition on lytB, lytC and lytB lytC D39 strains using a flow cytometry assay. (A) Proportion of C3b deposition at 30uC. (B)
Example of a flow cytometry histogram for C3b deposition at 30uC. (C) Proportion of C3b deposition at 37uC. (D) Example of a flow cytometry
histogram for C3b deposition at 37uC. Error bars represent the SDs and asterisks indicate statistical significance compared to the wild-type strain
(two-tailed Student’s t test; *, P,0.05; **, P,0.01; ***, P,0.001). P,0.001 (at 30uC and 37uC) for the comparison of the results for lytB lytC versus the
single mutants. For the results for all defective strains compared to wild-type strain at both temperatures, P,0.001 (one-way ANOVA with Dunnett’s
post hoc test). (E) Restoration of the C3b levels on lytB, lytC, and lytB lytC mutants in the presence of 2 mg of the indicated purified CWHs. Open bars
indicate C3b deposition without the addition of exogenous proteins (–), whereas blackened bars represent C3b levels in the presence of LytB, LytC or
a mixture of both proteins (+).
doi:10.1371/journal.pone.0023626.g003
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were calculated as a CI for bacteria recovered from BALF, lung,
and blood. Loss of LytB did not show impaired virulence at any of
the target sites analyzed confirming that the single mutation of
LytB does not have any effect on bacterial virulence within the
lung airway compartment (Figs. 7A to C). The CI of lytC vs. the
wild-type strain was significantly reduced in BALF and lung
Figure 4. Phagocytosis mediated by murine alveolar macro-
phages. (A) Adhesion of D39 wild-type strain and lytB, lytC and lytB lytC
strains to alveolar macrophages. (B and C) Phagocytosis of the wild-type
D39 and CWHs defective strains by alveolar macrophages. Error bars
represent the SDs and asterisks indicate statistical significance
compared to the wild-type strain (two-tailed Student’s t test;
*, P,0.05; **, P,0.01; ***, P,0.001). P,0.05 and P,0.01 for the
comparison of the results in adhesion and phagocytosis for lytB lytC vs.
lytB or lytC respectively. P,0.001 for the overall comparison in
phagocytosis (one-way ANOVA with a post hoc Dunnett test).
doi:10.1371/journal.pone.0023626.g004
Figure 5. Opsonophagocytosis mediated by human neutro-
phils using a flow cytometry assay. (A) Phagocytosis of D39 strain
and lytB, lytC and lytB lytC strains incubated in 20% human serum and
expressed as percent fluorescent indices relative to the results for the
wild-type D39 strain. (B) Example of a flow cytometry histogram for
phagocytosis. (C) Restoration of the levels of phagocytosis of lytB, lytC
and lytB lytC mutants in the presence of 2 m]g of the indicated purified
CWHs. Open bars represent phagocytosis without addition of proteins.
Grey bar shows phagocytosis of wild-type strain in the presence of LytB
and LytC proteins. Striped, blackened, and hatched bars indicate,
respectively, phagocytosis of lytB, lytC, or lytB lytC mutants in the
presence of LytB, LytC, or a mixture of both proteins, respectively. Error
bars represent SDs and asterisks represent statistical significance
compared to the wild-type strain (two-tailed Student’s t test;
*, P,0.05; **, P,0.01; ***, P,0.001). P,0.0001 for the overall
comparison in phagocytosis (one-way ANOVA with a post hoc Dunnett
test). For the comparison of the phagocytosis of the different mutant
strains compared to the phagocytosis in the presence of exogenous
proteins (P,0.05 for lytB and P,0.01 for lytC or lytB lytC mutants).
doi:10.1371/journal.pone.0023626.g005
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confirming that LytC is important for the establishment of
pneumococcal pneumonia in the respiratory tract (Fig. 7A and
B). Moreover, the bacteremia caused by the lytC mutant strain was
reduced after intranasal inoculation compared to the wild-type
strain, suggesting that LytC plays a significant role in the spread of
the bacteria from the lung to the systemic circulation (Fig. 7C).
The virulence of the double mutant lytB lytC strain was explored
using competitive indices and showed that loss of both CWHs had
a consistent impaired effect on virulence suggesting that the
combination of LytB and LytC is of great importance for full
virulence during pneumonia and invasive dissemination.
To explore whether loss of both LytB and LytC might have a
cooperative role on pneumococcal pneumonia, mixed infections
were performed by the intranasal route to compare the CIs of the
double lytB lytC strain vs. lytC with those obtained for the mixed
infection of lytB mutant vs. the wild-type strain. Our results show
that the CI of the lytB lytC vs. lytC was between 2–3 times lower in
the lung compartment (1.13 vs. 0.39 in BALF and 1.06 vs. 0.34 in
the lung; P,0.01) and nearly five times lower in blood (1.02 vs.
0.23; P,0.01) than the CI of the lytB vs. wild-type strain (Fig. 7D)
confirming that, although LytB may not have a direct role itself in
virulence, this CWH improves the pathogenesis mediated by LytC
in the establishment of pneumococcal pneumonia and enhances
the spread of the bacteria throughout the systemic circulation.
Discussion
S. pneumoniae is one of the most important human pathogens
responsible for serious diseases associated to high morbidity and
mortality rates worldwide [30]. Although the pneumococcal
capsule is essential for full virulence by preventing complement
immunity and phagocytosis [22,31], there are strong evidences
suggesting that structural components of the bacteria are also
important at different steps of the pathogenesis process [32].
Identification and functional analysis of gene products involved in
colonization, inflammation, and invasion is a key tool to
understand the host-pathogen interaction of S. pneumoniae and
provides essential knowledge that can be used to fight against this
pathogen with the discovery of new therapeutic targets or vaccine-
based strategies. Peptidoglycan is a major component of the
bacterial cell envelope that can be modified by the activity of
bacterial CWHs [33]. CWHs are a group of proteins whose role in
pathogenesis is not fully understood, although it is thought to be
important [4]. As peptidoglycan is one of the main pathogen-
associated molecular patterns targeted by the host innate immune
system, modifications of this essential and unique cell wall
component may be used by bacterial pathogens to subvert host
innate immunity [34,35]. Peptidoglycan hydrolases are required
for initial attachment to hydrophobic surfaces and contribute to
bacterial pathogenesis and full virulence by increasing the survival
within the systemic circulation, therefore enhancing the spread of
the bacteria throughout the host [36,37,38,39]. In this study we
have constructed single and double mutants in LytB and LytC to
investigate the impact of both proteins on pneumococcal
pathogenesis by exploring their role in the establishment of the
carrier state, invasive disease, and evasion of several host defence
mechanisms. Our findings demonstrate that both LytB and LytC
are important pneumococcal surface proteins involved in the
attachment to human nasopharyngeal cells, with a more marked
effect of LytC at 30uC, which is the physiological temperature
found in the upper respiratory tract and the optimal temperature
for this enzyme [10]. Previous results by Gosink and coworkers
[14] have shown that loss of function of LytC only moderately
reduced (30%) the adherence of S. pneumoniae to D562 cells at
30uC, whereas no effect was observed at 37uC. It should be noted,
however, that those authors employed a fluorescein isothiocya-
nate-labeled, nonencapsulated derivative of TIGR4 strain and a
very different methodology, i.e., pneumococcal cells were fixed
with glutaraldehyde before counting, and adherent bacteria were
quantified visually. These experimental conditions may have
introduced a significant bias on the results reported by those
authors. Using double lytB lytC defective TIGR4 and D39 strains
we evaluated the role of both CWHs in adhesion to nasopharyn-
geal cells. Our results demonstrate for the first time that the
attachment of S. pneumoniae to human nasopharyngeal cells was
dramatically impaired in the absence of both LytB and LytC
proteins with a maximum reduction at 30uC. The role of both
CWHs was also investigated in a mouse model of nasopharyngeal
colonization using a high bacterial challenge (107 CFU). This
inoculum results in colonization as well as invasion of the adjacent
mucosal sites without bacteremia [40]. Bacterial levels in the
nasopharynx were maintained between 104 and 105 CFU ml21
throughout the 7 days of the study. These results confirmed that
this model of nasopharyngeal colonization was self-limited and
similar to pneumococcal carriage in humans [41]. Our results
demonstrated that LytB and LytC are important CWHs involved
in the initial attachment to the nasopharynx although other
pneumococcal proteins also participate at this early stage as there
was some degree of colonization in the absence of both CWHs and
Figure 6. Role in virulence of the different strains using a sepsis
model of infection. (A) Virulence represented as a competitive index
(CI) of lytB, lytC and lytB lytC strains compared to their parental D39
wild-type strain. Error bars represent SDs of the means. For the
comparisons of the results of the CI of the lytC strain vs. lytB **, P,0.01
(two-tailed Student’s t test). For the comparisons of the double lytB lytC
strain vs. the single lytB or lytC strains ***, P,0.001 and *, P,0.05
respectively (two-tailed Student’s t test). (B) CIs of lytB strain compared
to strain D39 and CIs of lytB lytC mutants compared to lytC strain to
assess the combined effect of LytB and LytC in sepsis. **, P,0.01 for the
comparison of both CIs (two-tailed Student’s t test).
doi:10.1371/journal.pone.0023626.g006
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confirmed that the combination of LytB and LytC is required for
effective colonization of the respiratory tract over time. Targeting
mechanisms of preventing bacterial factors involved in the
colonization process during pneumococcal pathogenesis might
be an attractive strategy to prevent the pneumococcal carrier state.
Following adherence and asymptomatic colonization, S. pneu-
moniae must overcome host defense mechanisms implicated in the
recognition and clearance of the microorganism to gain access to
the alveolar space and/or the systemic circulation, producing
invasive disease. The complement system is an important
component of host immunity participating in the recognition
and phagocytosis of invading pathogens [42]. Evidence suggesting
that different proteins of S. pneumoniae are involved in the inhibition
of complement immunity and phagocytosis has been previously
published [18,29,43]. Our results demonstrate that loss of LytC,
but not LytB, increased C3b deposition at both 30uC and 37uC
demonstrating that LytC diverts C3b deposition on the bacterial
surface. This is the first evidence showing complement evasion
mediated by the pneumococcal lytic lysozyme. In addition, loss of
both LytB and LytC was associated with a markedly increased
C3b deposition on the bacterial surface confirming that the
combination of both proteins is very efficient in the diversion of
complement immunity.
The interaction with phagocytic cells was also investigated using
two different cell lines that are representatives of pneumococcal
phagocytosis [44,45]. lytB or lytC single mutants displayed an
increased uptake of S. pneumoniae by alveolar macrophages and
neutrophils, whereas the phagocytosis of the double mutant lytB
lytC was greatly enhanced compared to the single mutants. These
differences do not seem to be attributable to variations in cell
separation among the strains as it has been reported that the
average number of pneumococci per phagocyte is the same
between pneumococcal long-chain and short-chain variants [46].
Our results indicate that both CWHs are important pneumococcal
proteins involved in resistance to phagocytosis and demonstrate
that the presence of both LytB and LytC is highly effective in
evasion of pneumococcal phagocytosis. A clear correlation exists
between resistance to phagocytosis and carriage, where strains
more resistant to neutrophil clearance have an advantage to persist
in the nasopharynx [47]. The results of our study support this
hypothesis and suggest that one of the main virulence mechanisms
of LytB and LytC might be to avoid the recognition by
professional phagocytes within the upper respiratory tract allowing
the bacterium to efficiently colonize the nasopharynx. Targeting
these proteins by the use of a vaccine or a chemical drug might
help to reduce the carrier state by increasing the ability of the host
immune defense system to efficiently recognize S. pneumoniae from
the human nasopharynx. The addition of exogenous LytB and
LytC proteins to the single and double mutant strains restored
C3b levels to those found on the wild-type strain and increased the
resistance to phagocytosis to a similar degree than in the wild-type
isolate strongly suggesting that the phenotypes observed were
mainly due to the lack of LytB and LytC rather than other
unexpected genetic differences among the strains such as
insertions, duplications or second site mutations. Moreover, the
addition of choline binding proteins such as LytB and LytC to a
bacterial culture has been shown to recognize specifically the
choline residues located at the bacterial surface. Addition of GFP-
LytB to a lytB mutant strain binds the specific target (the polar
ends) to which it remains bound for a long time exhibiting a
dispersing effect typical of LytB, whereas exogenous addition of
the LytC lysozyme to a lytC deficient strain showed that this
enzyme was kept until regulatory control by the ‘‘cured’’ cells
[4,5]. These observations suggest that the addition of purified
hydrolases to the defective strains had the ability to compensate
the phenotype due to the lack of these enzymes.
Figure 7. Impact of mutations in the genes encoding LytB and LytC on pneumococcal pneumonia. (A to C) CIs of lytB, lytC and the
double lytB lytC strains compared to their parental D39 wild-type strain in BALF (A), lungs (B), and blood (C) after intranasal inoculation of a mixed
culture of the corresponding mutant with the wild-type strain. Error bars represent SDs of the mean and asterisks indicate results that are statistically
significant compared to those for the lytB strain which was outcompeted (two-tailed Student’s t test; *, P,0.05; **, P,0.01; ***, P,0.001). (D) CIs of
lytB vs. D39 (open bars) and lytB lytC vs. lytC (blackened bars) in BALF, lungs, and blood after intranasal infection. **, P,0.01 for the comparison of
both CIs at the corresponding sites of infection (two-tailed Student’s t test).
doi:10.1371/journal.pone.0023626.g007
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There is evidence supporting the idea that the factors needed for
pneumococcal infection may also be important in nasopharyngeal
colonization, as the majority of the genes required for invasive
disease were found to be required for bacterial carriage [48]. The
role of LytB and LytC in pneumococcal pneumonia and sepsis was
investigated using a mouse model of infection. Loss of LytB did not
influence virulence compared to the wild-type strain indicating
that LytB by itself does not participate in the establishment of
pneumonia or in systemic dissemination. These results are in
agreement with those found by other authors using a sepsis model
in which the virulence of a D39 lytB strain was very similar to the
corresponding wild-type strain [49]. However, the virulence of the
lytC mutant strain was attenuated in both models of systemic and
pulmonary infection with an impaired ability to spread from the
lung to the bloodstream confirming that LytC is an important
virulence factor of S. pneumoniae. In addition, the double lytB lytC
mutant strain was even more attenuated in virulence than the
corresponding single mutants or the wild-type strain. This
confirms that the presence of both LytB and LytC permits highly
effective establishment of pneumococcal pneumonia and sepsis
and indicates that both proteins enhance the dissemination of the
bacteria from the lung compartment to the systemic circulation.
This is in agreement with other authors confirming that different
virulence factors of S. pneumoniae act in concert increasing bacterial
virulence and reinforces the idea that several bacterial components
of S. pneumoniae are needed to efficiently produce invasive disease
[18,29,43,50].
In summary, we have shown that LytB and LytC are surface
exposed proteins that play a significant role in essential phases of
the pneumococcal pathogenesis such as nasopharyngeal coloniza-
tion, pneumonia, and sepsis. Our data suggest that pneumococcal
cell wall hydrolases are important proteins of S. pneumoniae involved
in the attachment of the bacteria to the nasopharynx and in the
progress of the pneumococcal pneumonia and sepsis by avoiding
complement immunity and phagocytosis.
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